3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Specimen Handling
5
Nivolumab
5
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
Biopsy
3
dehydroftorafur
2
Sigmoidoscopy
2
Radiotherapy, Intensity-Modulated
2
Proctoscopy
2
Paclitaxel
2
Mitozytrex
2
Mitomycin
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Colonoscopy
2
Carboplatin
2
Capecitabine
2
trastuzumab deruxtecan
1
entinostat
1
bintrafusp alfa protein, human
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Surveys and Questionnaires
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Radionuclide Imaging
1
Radiation
1
Phantoms, Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Erlotinib Hydrochloride
×
90 days
×
Clear all
No trials found.